MENU

Speakers


  • Matija Snuderl, MD

    Matija Snuderl, MD

    Director of Molecular Pathology

    BIOGRAPHY
  • Timothy Howard, PhD

    Timothy Howard, PhD

    Professor of Biochemistry

    BIOGRAPHY
JAN 31, 2024

The Illumina Epigenetics Experience

This virtual event welcomes industry scientists, government employees, and academic researchers interested in exploring the quickly evolving world of epigenetics! This 3-hr event, occurring on Wednesday January 31st, features presentations from leading epigenetics researchers. Presentations will highlight a broad range of topics, including recent advancements in the development & clinical implementation of molecular classifiers for cancer diagnoses in addition to exciting discoveries made by studying non-human primates.

Attend this event and you will have the opportunity to:

  • Learn how scientists at the forefront of their field are leveraging existing techniques and developing new methods for understanding the epigenome and its relevance for health
  • Network with likeminded scientists around the world who could be potential collaborators
  • Engage with Illumina product management, responsible for the development of the next generation of epigenetics tools 
  • Explore a virtual exhibit hall where you will find a broad range of educational content, Illumina technology product information, and case studies highlighting impressive research

Speakers
  • Matija Snuderl, MD

    Director of Molecular Pathology
    BIOGRAPHY
  • Timothy Howard, PhD

    Professor of Biochemistry
    BIOGRAPHY

Agenda

  • Experience with the EPIC BeadChip in Human and Non-human Primates
    JAN 31, 2024 11:00 AM EST

    Experience with the EPIC BeadChip in Human and Non-human Primates

    Timothy Howard, PhD
    Professor of Biochemistry
    BIOGRAPHY
    Sponsored By: Illumina
  • Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors - A prospective study and guidelines for clinical testing
    JAN 31, 2024 10:00 AM EST

    Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors - A prospective study and guidelines for clinical testing

    Matija Snuderl, MD
    Director of Molecular Pathology
    BIOGRAPHY
    Sponsored By: Illumina
Help

Connect with us